The Biggest Patent Cases of 2026 So Far: ANDA Litigation at the Supreme Court

In this episode of IP+ with Knobbe Martens, Jeremiah Helm, Co-Chair of Knobbe Martens’ Appellate Litigation practice, and Carol Pitzel Cruz, Co-Chair of the firm’s Hatch-Waxman Litigation practice, discuss one of the most consequential IP cases so far this year: the recent SCOTUS ruling in Hikma v. Amarin. In their discussion, Jeremiah and Carol break down the main issues at play in the ANDA litigation case, including generic drug manufacturers’ use of skinny labels, the nuances of induced infringement, and why the decision may reverberate beyond the pharmaceutical industry.

A full transcript of the episode can be found here.